Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,200Revenue $M13,576Net Margin (%)3.6Altman Z-Score2.0
Enterprise Value $M20,628EPS $2.2Operating Margin %10.2Piotroski F-Score6
P/E(ttm)28.2Beneish M-Score-2.5Pre-tax Margin (%)6.9Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %15.1Quick Ratio1.9Cash flow > EarningsY
Price/Sales1.05-y EBITDA Growth Rate %15.2Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow34.4y-y EBITDA Growth Rate %-17.6ROA % (ttm)2.6Higher Current Ratio y-yY
Dividend Yield %--PEG1.9ROE % (ttm)9.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M211ROIC % (ttm)7.5Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAArnold Van Den Berg 2015-12-31 Reduce-0.22%$67.79 - $78.16
($73.27)
$ 62.56-15%Reduce -6.22%268,133
DVAMario Gabelli 2015-12-31 Reduce$67.79 - $78.16
($73.23)
$ 62.56-15%Reduce -4.31%39,963
DVAArnold Van Den Berg 2015-09-30 Add1.63%$70.93 - $81.14
($77.54)
$ 62.56-19%Add 85.75%285,918
DVASteve Mandel 2015-09-30 Add0.75%$70.93 - $81.14
($77.54)
$ 62.56-19%Add 45.15%7,918,998
DVAJoel Greenblatt 2015-09-30 Buy 0.03%$70.93 - $81.14
($77.54)
$ 62.56-19%New holding48,381
DVAArnold Van Den Berg 2015-06-30 Reduce-0.11%$79.47 - $84.23
($82.11)
$ 62.56-24%Reduce -5.86%153,928
DVAMario Gabelli 2015-06-30 Add$79.47 - $84.23
($82.11)
$ 62.56-24%Add 5.29%41,763
DVAArnold Van Den Berg 2015-03-31 Buy 1.87%$72.78 - $82.84
($76.74)
$ 62.56-18%New holding163,503
DVASteve Mandel 2015-03-31 Add0.47%$72.78 - $82.84
($76.74)
$ 62.56-18%Add 38.47%5,455,774
DVAJoel Greenblatt 2015-03-31 Sold Out -0.22%$72.78 - $82.84
($76.74)
$ 62.56-18%Sold Out0
DVAMario Gabelli 2015-03-31 Reduce$72.78 - $82.84
($76.74)
$ 62.56-18%Reduce -7.25%39,663
DVASteve Mandel 2014-12-31 Buy 1.3%$72.03 - $78.07
($75.35)
$ 62.56-17%New holding3,940,169
DVAJoel Greenblatt 2014-12-31 Add0.16%$72.03 - $78.07
($75.35)
$ 62.56-17%Add 240.25%352,562
DVAMario Gabelli 2014-12-31 Reduce-0.03%$72.03 - $78.03
($75.28)
$ 62.56-17%Reduce -63.03%42,763
DVASteve Mandel 2014-06-30 Sold Out -1.1%$67.12 - $72.95
($69.49)
$ 62.56-10%Sold Out0
DVAJoel Greenblatt 2014-06-30 Reduce-0.11%$67.12 - $72.95
($69.49)
$ 62.56-10%Reduce -49.01%110,765
DVAMario Gabelli 2014-06-30 Add0.03%$67.12 - $72.95
($69.49)
$ 62.56-10%Add 330.08%114,328
DVASteve Mandel 2014-03-31 Reduce-1.31%$62.74 - $69.81
($66.3)
$ 62.56-6%Reduce -56.84%3,655,739
DVAMario Gabelli 2014-03-31 Buy 0.01%$62.74 - $69.81
($66.3)
$ 62.56-6%New holding26,583
DVASteve Mandel 2013-12-31 Add0.59%$55.03 - $63.39
($58.62)
$ 62.567%Add 34.41%8,470,777
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Mildenberger LauraChief People Officer 2015-12-17Sell1,440$68.14-8.19view
THIRY KENT JChairman and CEO 2015-11-09Sell300,000$75.61-17.26view
Rivera Kim MChief Legal Officer 2015-09-22Sell40,037$75.48-17.12view
DAVIDSON CAROL ANTHONYDirector 2015-08-17Sell4,038$79.93-21.73view
JIGANTI JEANINE MARIEChief Compliance Officer 2015-08-10Sell1,311$81.32-23.07view
BERG CHARLESDirector 2015-08-06Sell11,636$81.01-22.77view
Margolis Robert JCo-Chairman of the Board 2015-06-04Sell31,400$83.39-24.98view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2015-05-28Sell9,050$84.07-25.59view
Mildenberger LauraChief People Ofcr, Kidney Care 2015-05-20Sell9,579$83.15-24.76view
Margolis Robert JCo-Chairman of the Board 2015-05-19Sell31,400$82.73-24.38view

Press Releases about DVA :

Quarterly/Annual Reports about DVA:

News about DVA:

Articles On GuruFocus.com
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Starting With GAAP Jun 11 2015 
Berkshire Hathaway: Business Value Exceeds Market Value May 26 2015 
Manning & Napier's Top 5 Stock Selections of Q1 Apr 21 2015 
A Further Peek Into Ted Weschler’s Thought Process Apr 21 2015 
Texas Investor Arnold Van Den Berg Purchases 5 Stocks in Q1 Apr 14 2015 
Andreas Halvorsen Keeps Buying DVA, HLT, ACT Apr 10 2015 
A Peek into Ted Weschler’s Thought Process Mar 20 2015 
Seven Subscribers Win Contest to Name Buffett's Stock Buys in Fourth Quarter Mar 08 2015 

More From Other Websites
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces An Investigation of Claims against DaVita... Feb 12 2016
INVESTOR ALERT: GPM Commences Investigation on Behalf of DaVita Healthcare Partners, Inc. Investors Feb 12 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation DaVita Healthcare... Feb 12 2016
DaVita's Q4 Earnings Beat as Revenues Rise; Guides 2016 Feb 12 2016
Edited Transcript of DVA earnings conference call or presentation 11-Feb-16 10:00pm GMT Feb 12 2016
[$$] U.S. Investigating DaVita HealthCare Unit Feb 11 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita... Feb 11 2016
DaVita HealthCare Partners Inc Earnings Call scheduled for 5:00 pm ET today Feb 11 2016
DAVITA HEALTHCARE PARTNERS INC. Files SEC form 8-K, Other Events Feb 11 2016
DaVita HealthCare reports 4Q loss Feb 11 2016
DaVita HealthCare reports 4Q loss Feb 11 2016
4:08 pm DaVita beats by $0.15, reports revs in-line Feb 11 2016
DaVita HealthCare Partners Inc. 4th Quarter 2015 Results Feb 11 2016
Q4 2015 DaVita HealthCare Partners Inc Earnings Release - After Market Close Feb 11 2016
Can DaVita Healthcare (DVA) Q4 Earnings Pull a Surprise? Feb 09 2016
ABQ Health Partners parent firm launching into new kidney care space Feb 08 2016
DaVita HealthCare Partners Inc. Schedules 4th Quarter 2015 Investor Conference Call Feb 04 2016
Jim Rechtin Named President of HealthCare Partners' California Market Jan 21 2016
After-hours buzz: M, NFLX, UAL & more Jan 06 2016
DaVita (DVA) to Flourish on Inorganic Growth, High Debts a Drag Jan 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK